Julia Mohr
Impact in
-
- Genetic factors in colorectal cancer
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Gut microbiota and health 2
- Retinal Development and Disorders 2
- Genetics 8
- Chronic Lymphocytic Leukemia Research 6
- Neurogenetic and Muscular Disorders Research 2
- Co-authors
- B. G. Taal (2 shared papers)Riccardo Fodde (2 shared papers)Hans F. A. Vasen (2 shared papers)JT Wijnen (2 shared papers)F. M. Nagengast (2 shared papers)Lucio Bertario (2 shared papers)Liliana Varesco (2 shared papers)G Griffioen (1 shared paper)
- Journals
- Blood (4 papers)Gastroenterology (2 papers)Biochemical Journal (2 papers)Pediatric Nephrology (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Julia Mohr
27 papers receiving 1.9k citations
Julia Mohr's Hit Papers
Peers
Comparison fields: 5 of 93
- Pathology and Forensic Medicine 661
- Genetics 313
- Cancer Research 303
- Oncology 382
- Molecular Biology 747
Countries citing papers authored by Julia Mohr
This map shows the geographic impact of Julia Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Mohr more than expected).
Fields of papers citing papers by Julia Mohr
This network shows the impact of papers produced by Julia Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Mohr. The network helps show where Julia Mohr may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis Hit paper breakdown → | 1996 | 591 |
| 2 | 2017 | 303 | |
| 3 | 2013 | 207 | |
| 4 | 2009 | 206 | |
| 5 | 2008 | 205 | |
| 6 | 2019 | 62 | |
| 7 | 2013 | 53 | |
| 8 | 2020 | 33 | |
| 9 | 1991 | 31 | |
| 10 | 2010 | 30 | |
| 11 | 2009 | 26 | |
| 12 | 2014 | 24 | |
| 13 | 1987 | 24 | |
| 14 | 2020 | 20 | |
| 15 | 2008 | 18 | |
| 16 | Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis (vol 110, pg 1020, 1996) | 1996 | 17 |
| 17 | 2017 | 16 | |
| 18 | 2019 | 15 | |
| 19 | 2022 | 12 | |
| 20 | 2013 | 9 |
About Julia Mohr
Julia Mohr is a scholar working on Molecular Biology, Genetics, Pathology and Forensic Medicine, Oncology and Genetics, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer-related Molecular Pathways (2 papers), Gut microbiota and health (2 papers), Hereditary Neurological Disorders (2 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Retinal Development and Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (661 citations), Genetics (313 citations), Cancer Research (303 citations), Oncology (382 citations) and Molecular Biology (747 citations). Julia Mohr has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include B. G. Taal, Riccardo Fodde, Hans F. A. Vasen, JT Wijnen, F. M. Nagengast, Lucio Bertario, Liliana Varesco, G Griffioen, PM Khan and JH Kleibeuker. Their work appears in journals such as Blood, Gastroenterology, Biochemical Journal, Pediatric Nephrology and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.